NeuroOne® Medical Technologies to Present at the 2024 ThinkEquity Conference
NeuroOne Medical Technologies (Nasdaq: NMTC), a medical technology company specializing in neurological disorder treatments, has announced its participation in The ThinkEquity Conference on October 30, 2024. The event will be held at the Mandarin Oriental Hotel in New York. CFO Ron McClurg will deliver a presentation at 9:00 am ET, and the company will conduct one-on-one investor meetings throughout the day. The conference brings together institutional investors, corporate clients, and industry professionals to showcase innovations and financial strategies. The presentation will be available via live stream, and interested investors can register to attend and schedule meetings.
NeuroOne Medical Technologies (Nasdaq: NMTC), un'azienda di tecnologia medica specializzata nel trattamento dei disturbi neurologici, ha annunciato la sua partecipazione alla ThinkEquity Conference che si terrà il 30 ottobre 2024. L'evento si svolgerà presso l'hotel Mandarin Oriental di New York. Il CFO Ron McClurg farà una presentazione alle 9:00 ET e l'azienda organizzerà incontri individuali con gli investitori durante tutta la giornata. La conferenza riunisce investitori istituzionali, clienti aziendali e professionisti del settore per presentare innovazioni e strategie finanziarie. La presentazione sarà disponibile in streaming dal vivo, e gli investitori interessati possono registrarsi per partecipare e programmare incontri.
NeuroOne Medical Technologies (Nasdaq: NMTC), una empresa de tecnología médica especializada en el tratamiento de trastornos neurológicos, ha anunciado su participación en la ThinkEquity Conference que se llevará a cabo el 30 de octubre de 2024. El evento se celebrará en el hotel Mandarin Oriental en Nueva York. El CFO Ron McClurg realizará una presentación a las 9:00 a.m. ET, y la empresa llevará a cabo reuniones individuales con inversores a lo largo del día. La conferencia reúne a inversores institucionales, clientes corporativos y profesionales de la industria para mostrar innovaciones y estrategias financieras. La presentación estará disponible por transmisión en vivo, y los inversores interesados pueden registrarse para asistir y programar reuniones.
NeuroOne Medical Technologies (Nasdaq: NMTC), 신경 질환 치료에 특화된 의료 기술 회사가 2024년 10월 30일에 열리는 ThinkEquity Conference에 참여한다고 발표했습니다. 이 행사는 뉴욕의 만다린 오리엔탈 호텔에서 열릴 예정입니다. 최고 재무 책임자 Ron McClurg가 오전 9시(동부 표준시)에 발표를 진행하며, 회사는 하루 종일 투자자들과의 일대일 회의를 운영합니다. 이 회의는 기관 투자자, 기업 고객 및 산업 전문가들이 모여 혁신 및 재무 전략을 선보이는 자리입니다. 발표는 라이브 스트리밍으로 제공되며, 관심 있는 투자자는 참석 등록 및 회의 일정을 잡을 수 있습니다.
NeuroOne Medical Technologies (Nasdaq: NMTC), une entreprise de technologie médicale spécialisée dans le traitement des troubles neurologiques, a annoncé sa participation à la ThinkEquity Conference qui se tiendra le 30 octobre 2024. L'événement aura lieu à l'hôtel Mandarin Oriental à New York. Le directeur financier Ron McClurg présentera une communication à 9h00 HE, et l'entreprise organisera des réunions individuelles avec des investisseurs tout au long de la journée. La conférence réunit des investisseurs institutionnels, des clients d'entreprise et des professionnels du secteur pour présenter des innovations et des stratégies financières. La présentation sera disponible en streaming en direct, et les investisseurs intéressés peuvent s'inscrire pour y assister et planifier des réunions.
NeuroOne Medical Technologies (Nasdaq: NMTC), ein Medizintechnologieunternehmen, das sich auf die Behandlung neurologischer Störungen spezialisiert hat, hat seine Teilnahme an der ThinkEquity Conference am 30. Oktober 2024 angekündigt. Die Veranstaltung findet im Mandarin Oriental Hotel in New York statt. Finanzvorstand Ron McClurg wird um 9:00 Uhr ET eine Präsentation halten, und das Unternehmen wird den ganzen Tag über persönliche Investorenmeetings durchführen. Die Konferenz bringt institutionelle Investoren, Unternehmensklienten und Branchenprofis zusammen, um Innovationen und Finanzstrategien zu präsentieren. Die Präsentation wird über einen Livestream verfügbar sein, und interessierte Investoren können sich registrieren, um teilzunehmen und Meetings zu planen.
- None.
- None.
EDEN PRAIRIE, Minn., Oct. 24, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced that it will be participating in The ThinkEquity Conference on October 30, 2024, at the Mandarin Oriental Hotel in New York. The ThinkEquity Conference gathers institutional investors, corporate clients, and other industry professionals to highlight groundbreaking innovations and financial strategies.
Ron McClurg, CFO, will be presenting at 9:00 am ET on October 30th. The Company will also hold one-on-one investor meetings throughout the day. Interested investors can register to attend and schedule on-on-one meetings here.
The presentation will also be live-streamed at the following link: https://wsw.com/webcast/tep25/nmtc/1682208.
About ThinkEquity
ThinkEquity is a boutique investment bank founded by professionals who have collaborated for over a decade, collectively financing over
About NeuroOne
NeuroOne Medical Technologies Corporation is a developmental stage company committed to providing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders that may improve patient outcomes and reduce procedural costs. The Company may also pursue applications for other areas such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. For more information, visit www.nmtc1.com.
IR Contact
Quinn Callanan, CFA or Brian Prenoveau, CFA
MZ Group – MZ North America
NMTC@mzgroup.us
(949) 694-9594
FAQ
When is NeuroOne Medical Technologies (NMTC) presenting at the 2024 ThinkEquity Conference?
Where can investors watch NeuroOne's (NMTC) ThinkEquity Conference presentation?
What type of meetings will NeuroOne (NMTC) hold at the 2024 ThinkEquity Conference?
Where is the 2024 ThinkEquity Conference being held?
